| Diagnosis | |||
---|---|---|---|---|
 | RA/ inflammatory arthritis | OA | AVN | Other |
Overall moderate-severe ADL limitation | Â | Â | Â | Â |
Two-year follow-up | 67/140 (47.9%) | 1384/4714 (29.4%) | 115/389 (29.6%) | 83/192 (43.2%) |
 P-value compared to RA group |  | <0.01 | <0.01 | 0.43 |
Five-year follow-up | 45/97 (46.4%) | 911/2648 (34.4%) | 77/246 (31.3%) | 62/139 (44.6%) |
 P-value compared to RA group |  | 0.01 | 0.02 | 0.79 |
Moderate-severe hip pain | Â | Â | Â | Â |
Two-year follow-up | 7/142 (4.9%) | 355/4676 (7.6%) | 47/378 (12.4%) | 26/194 (13.4%) |
 P-value compared to RA group |  | 0.02 | 0.24 | 0.01 |
Five-year follow-up | 7/93 (7.5%) | 270/2651 (10.2%) | 37/244 (15.2%) | 25/142 (17.6%) |
 P-value compared to RA group |  | 0.07 | 0.41 | 0.03 |